Cargando…
A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796013/ https://www.ncbi.nlm.nih.gov/pubmed/35757844 http://dx.doi.org/10.1111/cea.14192 |
_version_ | 1784860385828929536 |
---|---|
author | Pablo‐Torres, Carmela Delgado‐Dolset, María Isabel Sanchez‐Solares, Javier Mera‐Berriatua, Leticia Núñez Martín Buitrago, Lucía Reaño Martos, Mar Bueno, José Luis Escribese, Maria M. Barber, Domingo Gomez‐Casado, Cristina |
author_facet | Pablo‐Torres, Carmela Delgado‐Dolset, María Isabel Sanchez‐Solares, Javier Mera‐Berriatua, Leticia Núñez Martín Buitrago, Lucía Reaño Martos, Mar Bueno, José Luis Escribese, Maria M. Barber, Domingo Gomez‐Casado, Cristina |
author_sort | Pablo‐Torres, Carmela |
collection | PubMed |
description | BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in the clinics for donation purposes. In this study, we designed a protocol based on plateletpheresis to obtain Platelet‐Rich Plasma (PRP), Platelet‐Poor Plasma (PPP) as well as CD3(+) and CD14(+) cells matched samples from a waste plateletpheresis product for immunological studies. METHODS: Twenty‐seven subjects were voluntarily subjected to plateletpheresis. PRP, PPP and blood cell concentrate contained in a leukocyte reduction system chamber (LRSC) were obtained in this process. CD3(+) and CD14(+) cells were isolated from the LRSC by density‐gradient centrifugation and positive magnetic bead isolation. RNA was isolated from PRP, CD3(+) and CD14(+) cell samples and used for transcriptomic studies by Affymetrix. PRP and PPP samples were used for platelet protein quantification by multiplex assays. RESULTS: A reliable high yield method to obtain matched samples of PRP, PPP, CD3(+) and CD14(+) from a single donor for RNA and protein analyses has been designed. The RNA quality indicators (RQI) routinely used for other cell types were not suitable for platelet RNA characterization. Despite this, the platelet RNA was valid for transcriptomic studies by Affymetrix, as platelet transcripts obtained in our previous studies were confirmed in PRP samples. Platelet samples were enriched in platelet factors as determined in protein multiplex analysis. CONCLUSIONS: We have developed a method that yields not only high content and pure platelet samples from a single donor but also CD3(+) and CD14(+) matched samples that can be used for RNA and protein analyses in immunological studies. |
format | Online Article Text |
id | pubmed-9796013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97960132022-12-28 A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies Pablo‐Torres, Carmela Delgado‐Dolset, María Isabel Sanchez‐Solares, Javier Mera‐Berriatua, Leticia Núñez Martín Buitrago, Lucía Reaño Martos, Mar Bueno, José Luis Escribese, Maria M. Barber, Domingo Gomez‐Casado, Cristina Clin Exp Allergy Original Articles BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in the clinics for donation purposes. In this study, we designed a protocol based on plateletpheresis to obtain Platelet‐Rich Plasma (PRP), Platelet‐Poor Plasma (PPP) as well as CD3(+) and CD14(+) cells matched samples from a waste plateletpheresis product for immunological studies. METHODS: Twenty‐seven subjects were voluntarily subjected to plateletpheresis. PRP, PPP and blood cell concentrate contained in a leukocyte reduction system chamber (LRSC) were obtained in this process. CD3(+) and CD14(+) cells were isolated from the LRSC by density‐gradient centrifugation and positive magnetic bead isolation. RNA was isolated from PRP, CD3(+) and CD14(+) cell samples and used for transcriptomic studies by Affymetrix. PRP and PPP samples were used for platelet protein quantification by multiplex assays. RESULTS: A reliable high yield method to obtain matched samples of PRP, PPP, CD3(+) and CD14(+) from a single donor for RNA and protein analyses has been designed. The RNA quality indicators (RQI) routinely used for other cell types were not suitable for platelet RNA characterization. Despite this, the platelet RNA was valid for transcriptomic studies by Affymetrix, as platelet transcripts obtained in our previous studies were confirmed in PRP samples. Platelet samples were enriched in platelet factors as determined in protein multiplex analysis. CONCLUSIONS: We have developed a method that yields not only high content and pure platelet samples from a single donor but also CD3(+) and CD14(+) matched samples that can be used for RNA and protein analyses in immunological studies. John Wiley and Sons Inc. 2022-07-16 2022-10 /pmc/articles/PMC9796013/ /pubmed/35757844 http://dx.doi.org/10.1111/cea.14192 Text en © 2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Pablo‐Torres, Carmela Delgado‐Dolset, María Isabel Sanchez‐Solares, Javier Mera‐Berriatua, Leticia Núñez Martín Buitrago, Lucía Reaño Martos, Mar Bueno, José Luis Escribese, Maria M. Barber, Domingo Gomez‐Casado, Cristina A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies |
title | A method based on plateletpheresis to obtain functional platelet, CD3
(+) and CD14
(+) matched populations for research immunological studies |
title_full | A method based on plateletpheresis to obtain functional platelet, CD3
(+) and CD14
(+) matched populations for research immunological studies |
title_fullStr | A method based on plateletpheresis to obtain functional platelet, CD3
(+) and CD14
(+) matched populations for research immunological studies |
title_full_unstemmed | A method based on plateletpheresis to obtain functional platelet, CD3
(+) and CD14
(+) matched populations for research immunological studies |
title_short | A method based on plateletpheresis to obtain functional platelet, CD3
(+) and CD14
(+) matched populations for research immunological studies |
title_sort | method based on plateletpheresis to obtain functional platelet, cd3
(+) and cd14
(+) matched populations for research immunological studies |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796013/ https://www.ncbi.nlm.nih.gov/pubmed/35757844 http://dx.doi.org/10.1111/cea.14192 |
work_keys_str_mv | AT pablotorrescarmela amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT delgadodolsetmariaisabel amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT sanchezsolaresjavier amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT meraberriatualeticia amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT nunezmartinbuitragolucia amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT reanomartosmar amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT buenojoseluis amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT escribesemariam amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT barberdomingo amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT gomezcasadocristina amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT pablotorrescarmela methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT delgadodolsetmariaisabel methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT sanchezsolaresjavier methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT meraberriatualeticia methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT nunezmartinbuitragolucia methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT reanomartosmar methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT buenojoseluis methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT escribesemariam methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT barberdomingo methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies AT gomezcasadocristina methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies |